Chronic Nonspecific Neck Pain and Central Nervous System Focused Treatment Program

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18-65
SponsorAcibadem University

About this trial

Neck pain is one of the most common musculoskeletal pain disorders secondary to low back pain. Pharmacological and non-medical treatments such as physiotherapy are applied in its treatment. Patients with chronic nonspecific neck pain (CNSP) can be treated with various interventions such as drug therapy, manual therapy, heat and exercise. However, it is also reported that chronic pain occurs as a result of neuroplasticity, that is, the brain learning pain through the central synthesis mechanism in the central nervous system. For this reason, although the importance of central nervous system-oriented therapies is increasing day by day, this system-oriented therapies are still ignored in clinics. Therefore, in this master's thesis study, it is aimed to investigate the effects of central nervous system-focused therapies (pain neuroscience education, breathing exercises and relaxation exercises with guided imagery) on pain, range of motion, functional status, pain-related fear, anxiety, depression and quality of life in addition to traditional physiotherapy applied to patients with CNSP.

Eligibility criteria

Qualifiers

Being diagnosed with nonspecific neck pain by a doctor,

To be between the ages of 18-65,

Having neck pain for more than 3 months

No previous neck or shoulder surgery,

Disqualifiers

Not meeting the inclusion criteria,

Positive neurological examination (positive motor presence, reflex or sensory abnormalities indicating spinal root compression) or abnormal neurological findings related to nerve compression in the upper limb

Systemic rheumatological or metabolic diseases or cancer

Refusal to participate in the study,

Trial design

Treatments tested in this trial

  • central nervous system focused treatment program
  • Classical Physiotherapy

Treatment groups

30 Participants
are divided into 2 treatment groups

Sponsors and collaborators